Journal of Medicinal Chemistry · 2009 · 36 citations · 5 references
PharmacyMedicinal ChemistryPharmacokineticsDrug DesignDrug DiscoveryVirologyAntiviral AgentsAntiviral PharmacologyPotency OptimizationAntiviral Drug DesignAntiviral Structure-activity RelationshipsNon-nucleoside InhibitorsNon-nucleoside Reverse Transcriptase InhibitorsNonnucleoside InhibitorsNucleoside Reverse Transcriptase InhibitorsSafety Profile CharacterizationSafety Studies
Biaryl ethers were recently reported as potent NNRTIs. Herein we disclose a detailed SAR study that led to the biaryl ether 6. This compound possessed excellent potency against WT RT and key clinically observed RT mutants and had an excellent pharmacokinetic profile in rats, dogs, and rhesus macaques. The compound also exhibited a clean safety profile in preclinical safety studies.
5
Thomas J. Tucker, John T. Sisko, Robert M. Tynebor et al. · Journal of Medicinal Chemistry · 2008 · 133 citations · Full text
Thomas J. Tucker, Sandeep Saggar, John T. Sisko et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 61 citations · Full text